Organon & Co | Pasivo Circulante



Current Liabilities Cambio Fecha
Adcock Ingram Holdings ZAR 2.53B 85.57M 2024-06
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Celltrion KRW 3.03T 141.48B 2024-09
Cspc Pharmaceutical CNY 9.63B 801.28M 2024-12
Dianthus Therapeutics USD 18.45M 2.74M 2024-12
Ecofibre AUD 20.78M 803K 2024-06
Gilead Sciences USD 12B 279M 2024-12
Glaxosmithkline GBP 21.7B 238M 2024-12
Kangmei Pharma CNY 4.91B 208.41M 2024-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 156.65M 115.81M 2024-12
Malin Corporation EUR 500K 500K 2024-06
Medical Developments International AUD 9.55M 1.61M 2024-06
Merck USD 28.42B 1.17B 2024-12
Neuren Pharmaceuticals AUD 45.76M 36.79M 2024-12
Novartis USD 28.69B 560M 2024-12
Organigram Holdings CAD 68.96M 15.64M 2024-12
Organon & Co USD 2.72B 72M 2024-12
Pharma Mar EUR 82.69M 6.75M 2024-12
Qiagen NV USD 543.63M 584.94M 2024-12
Sartorius EUR 977M 116.3M 2024-09
Sino Biopharmaceutical CNY 19.56B 2.39B 2024-12
Tilray USD 278.52M 15.02M 2024-11



Organon & Co Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.